Laboratory findings demonstrated significant hepatocellular injury with elevated liver enzymes (aspartate aminotransferase (AST): 1,043 U/L and alanine aminotransferase (ALT): 1,645 U/L), hyperbilirubinemia (total bilirubin: 4.8 mg/dL, direct bilirubin: 1.4 mg/dL), and hypokalemia (potassium: 2.8 mmol/L). This evidence concerns the gene GPT and Hypokalemia.